Rugby athlete receives sanction

  • Doping Violation Update

The Australian Sports Anti-Doping Authority (ASADA) today acknowledged the decision of Rugby Australia to impose a four year ban on athlete Reuben Leilua for presence and use of prohibited substances.

Mr Leilua returned an Adverse Analytical Finding following an In-Competition Doping Control Test on 20 August 2017 at the Queensland Premier Rugby Grand Final.

Mr Leilua breached the sport’s Anti-Doping Policy (ADP) for presence and use of:

Exogenous Androsterone, Etiocholanolone and 5β-androstane-3α,17β-diol (Presence);

Androsterone with and/or without one or more of the following substances:

  • Testosterone;
  • Androstenedione;
  • Androstenediol (Use).

Under category S1 of the World Anti-Doping Code Prohibited List 2017, Androsterone, Etiocholanolone, 5β-androstane-3α,17β-diol, Testosterone, Androstenedione and Androstenediol are prohibited both in-and out-of-competition.

Anabolic agents pose many threats to an athlete’s health and some side effects may include an increase in blood pressure and cholesterol levels which can lead to heart disease. Liver disease and infertility can also result from the use of these agents.

Mr Leilua is ineligible to participate in any sports that have adopted a World Anti-Doping Code compliant anti-doping policy until 5 February 2022.